In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.
Correction
Oct 4, 2004
Latest in Clinical News
New benchmark helps monitor cumulative CT radiation dose
February 13, 2026
Study questions routine use of radiotherapy after bone surgery
February 13, 2026
OncoRes secures $19M on path to U.S. trial
February 13, 2026















